当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析 - 利润表

和邦生物

(603077)

  

流通市值:144.83亿  总市值:144.83亿
流通股本:88.31亿   总股本:88.31亿

利润表

按照会计年度查询:
报告期2019-06-302018-09-302018-06-302018-03-31
一、营业总收入3,060,566,873.324,557,178,484.522,915,932,894.231,151,399,395.25
营业收入3,060,566,873.324,557,178,484.522,915,932,894.231,151,399,395.25
二、营业总成本2,713,600,707.954,066,038,053.152,623,163,160.681,095,127,446.17
营业成本2,383,886,069.613,535,935,334.962,286,063,850.54947,500,827.87
营业税金及附加23,298,203.7439,680,234.7727,555,472.449,011,911.4
销售费用152,186,768.24231,871,653.24135,033,819.2450,459,892.38
管理费用118,914,514.41167,409,117.19121,112,994.5668,051,859.56
财务费用16,983,371.8551,616,875.4340,586,737.2415,312,744.88
资产减值损失--18,540,259.4612,810,286.664,790,210.08
三、其他经营收益-12,049,519.67-45,445,150.54-8,354,656.38-58,356,745.41
允许价值变动净收益--------
投资净收益-1,169,175.7211,024,219.858,879,091.34-563,445.23
联营、合营企业投资收益3,372,551.153,903,320.871,816,165.32-563,445.23
汇兑净收益--------
四、营业利润346,358,476.22503,203,817.5302,364,958.7156,110,216.5
营业外收入4,457.11,905,814.73972,385.84971,180.09
营业外支出--3,880,118.63257,990.56242,570.78
非流动资产处置净损失--------
五、利润总额346,362,933.32501,229,513.6303,079,353.9956,838,825.81
所得税56,224,157.1584,272,888.2756,088,568.3113,220,488.49
未确认的投资损失--------
六、净利润(百万元)297.54113.09363.09448.44
少数股东损益-7,400,744.68-31,480,824.3-26,818,341.56-6,191,294.11
归属于母公司股东的净利润297,539,520.85448,437,449.63273,809,127.2449,809,631.43
七、每股收益0.030.05----
基本每股收益0.030.050.030.01
稀释每股收益0.030.050.030.01
TOP↑